Skip to main content

Advertisement

Log in

Living-donor liver transplantation providing an adequate chemotherapy for a pediatric patient with anaplastic large cell lymphoma complicated with liver failure due to the aggravation of biliary hepatopathy by secondary hemophagocytic lymphohistiocytosis

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Anaplastic large cell lymphoma (ALCL) accounts for 10–15% of childhood non-Hodgkin lymphoma cases; it is generally chemo-sensitive and is one of the most curable pediatric cancers. We report here a case of pediatric ALCL complicated with acute liver failure due to the aggravation of pre-existing biliary hepatopathy by lymphoma-associated hemophagocytic lymphohistiocytosis (HLH). Although the initial treatment response against ALCL was very good, poor and irreversible liver function due to biliary cirrhosis worsening by lymphoma-associated HLH prevented the patient from receiving further consolidation chemotherapies. To make matters worse, his condition was accompanied with intrahepatic fungal pseudoaneurysm and invasive fungal infection. Thus, we decided to perform an urgent living-donor liver transplantation from his father to correct the patient’s liver function and make it possible to proceed with further ALCL therapy. After the living-donor liver transplantation, the patient successfully received consolidation therapy with brentuximab vedotin. To our knowledge, this may be an early reported case of a pediatric patient undergoing liver transplantation during treatment for ALCL. In most patients with HLH-associated ALCL, liver function improves when ALCL is controlled. However, acute liver failure is occasionally observed in HLH cases with pre-existing liver dysfunction. In such cases, liver transplantation should be considered to correct liver dysfunctions if the disease control of HLH is satisfactory.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Alessandri AJ, Pritchard SL, Schultz KR, Massing BG. A population-based study of pediatric anaplastic large cell lymphoma. Cancer. 2002;94:1830–5.

    Article  Google Scholar 

  2. Amin HM, Lai R. Pathobiology of ALK + anaplastic large-cell lymphoma. Blood. 2007;110:2259–67.

    Article  CAS  Google Scholar 

  3. Wrobel G, Mauguen A, Rosolen A, Reiter A, Williams D, Horibe K, et al. Safety assessment of intensive induction therapy in childhood anaplastic large cell lymphoma: report of the ALCL99 randomised trial. Pediatr Blood Cancer. 2011;56:1071–7.

    Article  Google Scholar 

  4. Locatelli F, Mauz-Koerholz C, Neville K, Llort A, Beishuizen A, Daw S, et al. Brentuximab vedotin for paediatric relapsed or refractory Hodgkin’s lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study. Lancet Haematol. 2018;5:e450–61.

    Article  Google Scholar 

  5. Ishii E, Ohga S, Imashuku S, Yasukawa M, Tsuda H, Miura I, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86:58–65.

    Article  Google Scholar 

  6. Ryu JM, Kim KM, Oh SH, Koh KN, Im HJ, Park CJ, et al. Differential clinical characteristics of acute liver failure caused by hemophagocytic lymphohistiocytosis in children. Pediatr Int. 2013;55:748–52.

    Article  Google Scholar 

  7. Ramos-Casals M, Brito-Zerón P, López-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014;383:1503–16.

    Article  Google Scholar 

  8. Wang H, Xiong L, Tang W, Zhou Y, Li F. A systematic review of malignancy-associated hemophagocytic lymphohistiocytosis that needs more attentions. Oncotarget. 2017;8:59977–85.

    Article  Google Scholar 

  9. Lehmberg K, Sprekels B, Nichols KE, Woessmann W, Muller I, Suttorp M, et al. Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents. Br J Haematol. 2015;170:539–49.

    Article  Google Scholar 

  10. Pasqualini C, Minard-Colin V, Saada V, Lamant L, Delsol G, Patte C, et al. Clinical analysis and prognostic significance of haemophagocytic lymphohistiocytosis-associated anaplastic large cell lymphoma in children. Br J Haematol. 2014;165:117–25.

    Article  Google Scholar 

  11. Bergsten E, Horne A, Arico M, Astigarraga I, Egeler RM, Filipovich AH, et al. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood. 2017;130:2728–38.

    Article  CAS  Google Scholar 

  12. Amir AZ, Ling SC, Naqvi A, Weitzman S, Fecteau A, Grant D, et al. Liver transplantation for children with acute liver failure associated with secondary hemophagocytic lymphohistiocytosis. Liver Transpl. 2016;22:1245–53.

    Article  Google Scholar 

  13. Ayvazoğlu Soy EH, Alam H, Olcay L, Barış Z, Yıldırım S, Torgay A, et al. Liver transplant in a patient with hemophagocytic lymphohistiocytosis. Exp Clin Transplant. 2019;17:226–9.

    Article  Google Scholar 

  14. Cuenca AG, Kim HB, Vakili K. Pediatric liver transplantation. Semin Pediatr Surg. 2017;26:217–23.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank Kaoru Yoshida of the Department of Pediatric Hematology and Oncology Research, National Center for Child Health and Development for performing the RT-PCR and direct sequencing of NPM-ALK.

Author information

Authors and Affiliations

Authors

Contributions

KS collected data and provided medical care for this case, and wrote the manuscript supported by MK and DT. TO, SY, SS, MK, DT, SS, OM, SN, MK, and KM provided medical care for this case. TD and NK performed flow-cytometric analysis. NN, TY, and RI performed pathological diagnostic procedures. All authors commented on the manuscript and contributed to the final manuscript.

Corresponding author

Correspondence to Kenichi Sakamoto.

Ethics declarations

Conflict of interest

The authors declare no competing financial interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

12185_2020_2949_MOESM1_ESM.pdf

Supplementary material 1 (PDF 223 kb) Figure 1. Image findings at 12 months post-liver transplantation and at 8 months after cessation of chemotherapy. A, B Abdominal computerized tomography (CT) shows no hepatosplenomegaly nor lymphadenopathy; C, D positron emission tomography with CT (PET-CT) reveals no high radiotracer accumulation at lymph nodes.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sakamoto, K., Osumi, T., Yoshimura, S. et al. Living-donor liver transplantation providing an adequate chemotherapy for a pediatric patient with anaplastic large cell lymphoma complicated with liver failure due to the aggravation of biliary hepatopathy by secondary hemophagocytic lymphohistiocytosis. Int J Hematol 112, 900–905 (2020). https://doi.org/10.1007/s12185-020-02949-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-020-02949-z

Keywords

Navigation